Wide Ranks

CTOR

Citius Oncology, Inc.

0.9402

Top Statistics
Market Cap 67 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 0.32 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash Total Cash Per Share Total Debt
Total Debt To Equity Current Ratio 0.32 Book Value Per Share 0.2520
All Measures
Short Ratio 29.00 % Message Board Id finmb_1859892474 Shares Short Prior Month 10597
Return On Equity -0.8528 City New York Uuid 5675f0f3-7b48-33fa-8e62-6754524e2ae6
Previous Close 0.9959 First Trade Date Epoch Utc 1 B Book Value 0.2520
Volume 70245 Price To Book 3.73 Fifty Two Week Low 0.8500
Shares Short Previous Month Date 1 B Target Median Price 3.00 Max Age 86400
Recommendation Mean 2.00 Sand P52 Week Change 0.3133 Target Mean Price 3.00
Net Income To Common -19523486 Ask 1.09 Implied Shares Outstanding 71 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 65900
Average Volume10days 65900 Next Fiscal Year End 1 B Held Percent Insiders 0.9588
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 0.9959 Target Low Price 3.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.19 Open 0.9950 Free Cashflow 7 M
State NY Dividend Yield 0.00 % Return On Assets -0.2423
Time Zone Short Name EST Trailing Eps -0.1800 Day Low 0.9200
Address1 420 Lexington Avenue Shares Outstanding 71 M Price Hint 4
Target High Price 3.00 52 Week Change -0.9139 Average Volume 128314
Recommendation Key buy Forward Eps 0.0000 Is_sp_500 False
Regular Market Day High 1.07 Profit Margins 0.00 % Fifty Two Week High 49.00
Day High 1.07 Shares Short 29767 Regular Market Open 0.9950
Industry Key drug-manufacturers-specialty-generic Bid 0.9441 Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0004 Currency USD
Time Zone Full Name America/New_York Market Cap 67 M Is_nasdaq_100 False
Zip 10170 Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic
Long Name Citius Oncology, Inc. Regular Market Day Low 0.9200 Held Percent Institutions 0.0073
Current Price 0.9402 Address2 Suite 2446 Financial Currency USD
Current Ratio 0.32 Industry Disp Drug Manufacturers - Specialty & Generic Number Of Analyst Opinions 1
Country United States Float Shares 4 M Two Hundred Day Average 8.34
Forward PE 0.0000 Regular Market Volume 70245 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies.

It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma.

The company is headquartered in New York, New York.

Citius Oncology, Inc.  operates as a subsidiary of Citius Pharmaceuticals, Inc.